RT Generic
T1 A mutually beneficial collaboration between the European Academy of Allergy and Clinical Immunology Junior Members and Clinical and Translational Allergy
A1 Tomazic, Peter Valentin
A1 Graessel, Anke
A1 Silva, Diana
A1 Eguiluz-Gracia, Ibon
A1 Guibas, George V.
A1 Grattan, Clive
A1 Bousquet, Jean
A1 Tsilochristou, Olympia
K1 EAACI
K1 Junior Members
K1 Clinical and Translational Allergy
K1 Collaboration
K1 Allergy
K1 International consensus
K1 Asthma
K1 Hypersensitivity
K1 Cells
AB The European Academy of Allergy and Clinical Immunology (EAACI) Junior Members (JM) comprise the largest EAACI section with around 4000 clinicians and scientists under 35 years of age working in the field of allergy and clinical immunology. The Junior Member collaboration with Clinical and Translational Allergy Journal is a mutually beneficial relationship providing Junior Members of EAACI with excellent opportunities to publish their work in the Journal, enhance their visibility in their respective field, and get involved with Journal-related activities and processes. In the future, this collaboration will grow, not only by the consolidation of these activities, but also by the implementation of new initiatives, such as a platform for discussing and/or publishing Junior Members' dissertations in the Journal. From the CTA perspective, the collaboration presents an opportunity to promote a new generation of allergists with experience of conducting and presenting research, with improved skills in critical review.
PB BioMed Central
SN 2045-7022
YR 2016
FD 2016-12-01
LK http://hdl.handle.net/10668/19134
UL http://hdl.handle.net/10668/19134
LA en
NO Tomazic PV, Graessel A, Silva D, Eguiluz-Gracia I, Guibas GV, Grattan C, et al. A mutually beneficial collaboration between the European Academy of Allergy and Clinical Immunology Junior Members and Clinical and Translational Allergy. Clin Transl Allergy. 2016 Dec 1;6:43
DS RISalud
RD Apr 6, 2025